Results due soon and a calm stock market that awaits them – this is Soligenix Inc(OTC:SNGX). A financially stable OTC enterprise, which is not very common, one that follows a pattern of either slow and steady decline over time, or one of stability and slow and methodical growth of the stock price. 
It looks as if this year is one which would follow the optimistic scenario. What is more, Soligenix is not the type of stock you could expect to make a quick 100% return on your investment. There are some cases back in 2009 when shocking increase and decrease of the stock price would take place in a matter of days, but they are rather an exception to the rule. This week is not. Yesterday was another session with a 2% increase in the stock price, supported by a little less than a million shares changing hands. Yet, since last December the total increase of the price is over 50%
Now, as mentioned, Soligenix shares a somewhat far more positive balance sheet than most penny stock enterprises. Among other figures, the last 10K covering 2010 includes the following:
- total current assets of $8 million; [BANNER]
- total current liabilities of $1.9 million;
The net loss and accumulated deficit, however, are still in numbers that are hard not to notice. Yet, Soligenix is a late stage development company. This means that the time is coming to show whether there was a point for shareholders to stick with it over time. As mentioned, Phase 3 Trial Results are to be announced in the next few months, which could in terms cause a never seen before activity and movement on the stock market. Yet, until that point comes, caution should also be exercised when considering an investment in this enterprise.
